Does pharmaceutical-funded research produce biased reports in medical journals?

In 2003, when diabetes drug Avandia was released, The New England Journal of Medicine published an article about how the drug outperformed two leading competitors in a clinical trial. The study was funded by GlaxoSmithKline, the makers of Avandia; four of the authors were GSK employees, and the others had received support as consultants. The article failed to mention that Avandia showed early warn....
Source: Sound Medicine - Category: Global & Universal Authors: Source Type: news